Cash Flow

v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (4,554) $ (3,407)
Reconciliations of net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 1,297 1,000
Non-cash lease expense 1,872 1,724
Investment amortization and losses recognized 203 81
Deferred Income taxes   508
Share-based compensation 1,060 342
Changes in certain operating assets and liabilities:    
Trade accounts receivable (88,924) (2,229)
Income taxes (1,724) (1,102)
Prepaid expenses and other 1,348 (1,592)
Accounts payable 865 (1,660)
Accrued payroll, payroll taxes and related benefits 83,926 6,406
Other accrued liabilities 964 (2,095)
Workers' compensation claims liabilities 5,273 6,452
Safety incentives liability (7,573) (1,620)
Operating lease liabilities (1,887) (1,672)
Other assets and liabilities, net (30) (95)
Net cash (used in) provided by operating activities (7,884) 1,041
Cash flows from investing activities:    
Purchase of property, equipment and software (1,781) (3,439)
Purchase of investments (23,444) (23,722)
Proceeds from sales and maturities of investments 9,381 21,758
Purchase of restricted investments (132,788) (1,828)
Proceeds from sales and maturities of restricted investments 24,286 14,449
Net cash (used in) provided by investing activities (124,346) 7,218
Cash flows from financing activities:    
Payments on long-term debt (55) (55)
Repurchase of common stock (3,436) (2,987)
Common stock repurchased on vesting of stock awards (107) (378)
Dividends paid (2,278) (2,262)
Proceeds from exercise of stock options 815 904
Net cash used in financing activities (5,061) (4,778)
Net (decrease) increase in cash, cash equivalents and restricted cash (137,291) 3,481
Cash, cash equivalents and restricted cash, beginning of period 233,837 273,341
Cash, cash equivalents and restricted cash, end of period $ 96,546 $ 276,822

Source